our heritage STEEPED IN SCIENCE.
LOVED BY PHYSICIANS.
Originally crafted for vulnerable post-procedure skin, Colorescience® designs health-forward skincare solutions for women of all ages and skin types, so they feel reassured and confident.
Today, Colorescience is the fastest growing professional skincare brand in the US, leading innovation in sun protection. We expand that innovation into a broad line of skincare and color correction products, in a way that consumers love to wear every day.
We are proud to say every single one of our SPF products has always been, and always will be formulated with only 100% mineral active ingredients—zinc oxide and titanium dioxide—to provide the safest physical protection possible.
seasoned + proven leadership driving results
Our executive leadership team has deep expertise in life sciences and innovation, across a varied collection of industries. These seasoned leaders each have a proven track record of driving growth and meaningful financial results within their respective organizations. While we remain laser-focused on building the business, as members of the Colorescience executive team, we are also unified by a passion for the brands mission: protecting lives the safest way we can, one skincare innovation at a time.
Mary Fisher, Chief Executive Officer SkinMedica, Acorda, Cephalon, Immunex
Steve Loomis, Chief Financial Officer SkinMedica, CardioDynamics, Terminal Data Corp, Kinkos
Ted Ebel, Chief Business Officer SkinMedica, Amgen, CancerVax, Mp3
Christina Balesteri, VP Internal & External Customers SkinMedica, Allergan
Patricia Boland, VP Research & Development Laura Mercier, Gurwitch Products
Heather Goodchild, VP Professional Business SkinMedica, Allergan, PharmaDerm
John Shortley, VP Finance Allergan, CardioDynamics, AMN Healthcare, TurboChef
Sanem Ahearn, VP Marketing Alberto Culver (Unilever), Dell, FTD, Siemens
Board of Directors
Josh Baltzell is a Managing Director with Split Rock Partners. He joined the Firm's at its inception in 2005 and provides the healthcare team with an extensive background in the medical device industry, having been involved in virtually all aspects from product development to the acquisition and sale of mature organizations.
Prior to joining Split Rock Partners, Josh served as a Principal with St. Paul Venture Capital's healthcare team, which he joined in 2002. He joined St. Paul Venture Capital from Piper Jaffray where he held the position of vice president in the healthcare investment banking group. During his tenure there, he was involved in a broad range of investment banking activities including private and public equity financings as well as mergers and acquisitions on the buy and sell side.
Prior to joining Piper Jaffray, Josh spent several years in various marketing and business development positions in the medical device industry including vice president, marketing and business development for a medical device start-up and group product manager - emerging technologies for SCIMED/Boston Scientific.
Josh graduated from St. Olaf College and has an MBA from the University of Minnesota's Carlson School of Management.
Mary Fisher is Chair, Chief Executive Officer and Board Director at Colorescience, a former division of SkinMedica Inc., where she served as Chief Executive Officer from 2008 until 2012. She led the successful sale of the company to Allergan, Inc. for $350 million with the potential for another $25 million contingent on certain sales milestones. Ms. Fisher has more than 30 years in the pharmaceutical and biotechnology industries, including management and leadership positions at Acorda Therapeutics, Cephalon, Immunex and Boehringer Ingelheim. She serves on the board of directors of Sientra and MDRejuvena. In 2013, Ms. Fisher was honored as Ernst & Young's Entrepreneur of the Year for San Diego and also received the EY Venture Capital Award of Excellence. Ms. Fisher was also recently named a finalist for Most Admired CEO by the San Diego Business Journal in 2018.
Ms. Hou is a Principal at Montreux Equity Partners and an experienced healthcare investor.
Ms. Hou is actively involved in Montreux’s investments and currently serves on the board of Colorescience and KFx Medical and as a board observer at TigerConnect. She also works closely with a number of Montreux portfolio companies, including Crown Laboratories and KNOW Foods. She had represented Montreux on the board of SI-BONE (NASDAQ: SIBN) and had managed Montreux’s investment in Tobira Therapeutics (NASDAQ: TBRA, acquired by Allergan). Previously, she was at Quaker Partners, a healthcare investment firm, where she evaluated and executed investments in biopharmaceutical, medical device, diagnostics, healthcare services, and consumer healthcare companies. Prior to joining Quaker, Ms. Hou was a Managing Consultant at Navigant Consulting, where she led and conducted numerous projects in commercial strategy and business development advisory for healthcare clients, including large-cap and specialty pharmaceutical, biotechnology, and healthcare services companies. Ms. Hou also worked in marketing at Abbott on the global launch of its bioresorbable stent. She has contributed to policy and research initiatives supporting regulatory reform with the Medical Innovation and Competitiveness (MedIC) Coalition and National Venture Capital Association (NVCA).
Ms. Hou earned an M.B.A. from Stanford Graduate School of Business and a B.A. in Human Biology and English from Stanford University.
Nicky Kinnaird is a long-time, esteemed innovator in the beauty industry. She revolutionized retail beauty in the early 1990’s with the launch of Space NK Apothecary in London’s Covent Garden. The ground-breaking boutique featured a curated mix of beauty and wellbeing lines and quickly grew into an international beauty mecca—known for offering consumers a unique selection of the finest established and burgeoning brands. Having stepped down from her Space NK duties over 2 years ago, Kinnaird has fed her passion for the evolution of consumer-focused beauty by consulting on growing brands.
Alex Morgan became the youngest member of the U.S. women's national soccer team in 2009, and was the first overall pick in the 2011 Women's Professional Soccer draft. At the 2012 Summer Olympic Games, Morgan won her first Olympic gold medal by helping the U.S. women defeat Japan. Three years later, she was a leader on the team that again defeated Japan to win the FIFA Women's World Cup. In 2019, she was the co-captain of the team that once again captured World Cup title and as was named by Time magazine one of the most influential people of the year. In addition to her role as the captain of the US Women’s National Soccer team, she is a businesswoman, author, social media icon, and a staunch defender of gender equality along with her USWNT teammates.
Adele Oliva brings decades of finance and healthcare experience to 1315 Capital, including 20 years in private equity focused on commercial stage specialty pharmaceutical, medical technology, and healthcare service investments.
Adele co-founded 1315 Capital in 2015 to establish a firm focused on healthcare growth investing. She was recruited to Quaker Partners in 2007 to expand their growth stage investing practice. Prior to Quaker, Adele was Co-Head of US Healthcare at Apax Partners, where she started in 1997.
Forbes recognized Adele on its Midas List of top 100 technology investors worldwide, top 10 life science investors and top women in venture capital.
Adele has served on the board of Ascent Healthcare Solutions (acquired by Stryker), EKR Therapeutics (acquired by Cornerstone Therapeutics), ESP Pharma (acquired by Protein Design Labs), Esprit Pharma (acquired by Allergan), Precision Dermatology (acquired by Valeant), Prometheus Labs (acquired by Nestle) and SkinMedica (acquired by Allergan). She currently serves on the boards of Colorescience, Genoptix, Innovative Health, NovaSom, Onkos Surgical, and TELA Bio.
Prior to entering private equity as a Kauffman Fellow, Adele held roles at CoreStates in commercial banking and Baxter Healthcare in marketing and business development.
Adele received a BSc from St. Joseph’s University and an MBA from Cornell University, where she was awarded the Albert Fried Fellowship.
David Olsen is the Chief Executive Officer (CEO) of Cos Bar, the original 40-year-old specialty beauty retailer in the U.S. Cos Bar is recognized for disrupting the luxury beauty industry with its unique and engaging sales experience focused on the needs of the client and its carefully curated array of the world’s best beauty brands.
Since joining in February 2016, David has worked to grow the company while maintaining a commitment to delivering a seamless omnichannel experience for clients, wherever they are and whichever device they are on. In his short tenure, David’s team opened 6 stores, bringing the total store count to 20; opened corporate headquarters in Los Angeles; refreshed the brand identity and store environment; relaunched cosbar.com; and introduced Cos Bar’s first loyalty rewards program, B. Cos. With David’s guidance, Cos Bar will operate 50 doors nationwide by 2021.
David has been in the retail space as a strategist and operator for over 17 years. Prior to joining Cos Bar, he was the global vice president of Beauty and Grooming at The Net-A-Porter Group, where he developed and executed that strategy from 2012 to 2016. In 2000, David started his own e-commerce cosmeceutical business which was later sold to DermStore.com, leading to the creation of the largest pure play beauty destination in the US, ultimately selling to Target. David brings his digital expertise and growth focus to Cos Bar to ensure the execution of their mission to deliver the world’s best luxury beauty buying experience.
Ty Stiklorius is the Founder and CEO of Friends At Work, an entertainment, media and impact agency that partners with the world’s greatest artists and thinkers. Ty launched FAW in 2015 and manages a diverse roster of artists and influencers including John Legend, Ciara, Lindsey Stirling, Rooty, Cynthia Erivo, Madame Gandhi and ItsTheReal.
Alongside Legend and Mike Jackson, Ty is also one of the principals of Get Lifted Film Co., a film and TV production company based in Los Angeles. Under the Get Lifted, banner, the trio has served as Executive Producers on the HBO documentary “Southern Rites,” WGN’s hit series “Underground” and the award-winning film “La La Land.”
Ty’s work with John Legend began with the formation of JL Ventures in 2006, where she created strategies for innovation, business development and social impact built on the artist’s unique vision and desire to do good in the world. From there, they launched The Show Me Campaign, with a mission to give every child access to a quality education. In 2015, Ty and Legend started the #FREEAMERICA campaign to shift the national conversation around our country’s misguided incarceration policies. Ty is also co-founder of Prosecutor Impact, which works to highlight the power of the prosecutor to shape outcomes in the criminal justice system.
Ty earned an MBA from The Wharton School of Business as well as a BA from The University of Pennsylvania. She serves on the board of LIFT Communities, a national non-profit dedicated to helping families break the cycle of poverty. Ty is also on the board of LRNG, a social enterprise that works with schools, businesses, and cities and community institutions to redesign learning so all youth have the opportunity to succeed.